Orostachys japonicus A. Berger (O. japonicus) extracts have shown various biological activities including anti-inflammatory, neuroprotective, anti-ulcerative, anti-oxidant, and anti-tumor effects. Particularly, it has been recognized as a potential an...
Orostachys japonicus A. Berger (O. japonicus) extracts have shown various biological activities including anti-inflammatory, neuroprotective, anti-ulcerative, anti-oxidant, and anti-tumor effects. Particularly, it has been recognized as a potential anti-tumor agent against various tumor cells. In the present study, the anti-tumor effect of O. japonicus extracts on intrahepatic cholangiocarcinoma cell line SNU-1079 was investigated. Cells were treated with various concentrations of O. japonicus DW and EtOH extracts (0-300 ㎍/㎖) for 24, 48, or 72 h. Cell viability was evaluated through PMS/MTS assay, and the apoptosis rate was examined through ELISA assay and flow cytometry analysis. The mRNA expression of apoptosis- and cell cycle-related genes (Bcl-2, Mcl-1, Bax, Survivin, Cyclin D1, and p21) was evaluated using real-time PCR, and the caspase activity was examined using immunoblot analysis. O. japonicus extracts inhibited cell proliferation and increased apoptosis rate in both ELISA assay and flow cytometry analysis. O. japonicus extracts decreased Bcl-2, Mcl-1, Survivin, and Cyclin D1 mRNA expression and increased Bax mRNA level. O. japonicus extracts also increased Caspase-3 activation. Overall, O. japonicus DW extracts were more effective than EtOH extracts. Taken these results together, O. japonicus inhibited cell proliferation and induced apoptosis in SNU-1079 cells via mitochondria-mediated intrinsic pathway, which leads to Caspase-3 activation. The results indicate that O. japonicus is a potential therapeutic herb with anti-tumor effect against intrahepatic cholangiocarcinoma.